Mediwelcome Healthcare Management & Technology (HKG:2159) expects to narrow its loss by 82% in the first half of 2025 to approximately 4.1 million yuan from 23 million yuan a year prior, a late Monday Hong Kong bourse filing said.
Shares of the integrated healthcare marketer were down nearly 3% in Tuesday afternoon trading.
The firm attributed the forecast to a higher gross profit and lower R&D and administrative expenses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.